RIPK3 and neoplasm: Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-deficient TAMs enhance M2 polarization via fatty acid oxidation, whereas decitabine modulates metabolism to boost anti-tumor immunity (8).